Diagnosis Of Hep C Update Aug%20 09pdf
HIV/HCV Coinfection News – HCV Protease Inhibitors Juergen Rockstroh, MD Marc Poliquin, MD.
SILEN-C2: sustained virological response (SVR) and safety of BI 201335 combined with peginterferon alfa 2a and ribavirin (PegIFN/RBV) in chronic HCV genotype-1.
Www.ias2013.org Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Access to HCV triple therapy with Telaprevir or Boceprevir in a real-life setting in HIV-HCV.
Protease and Polymerase Inhibitors for the Treatment of Hepatitis C Tarik Asselah MD, PhD Service d’Hépatologie & INSERM U773, CRB3 Hôpital Beaujon, Clichy.
